Xofigo 1100 kBq/ml Ra-223-Dichlorid
As listed in the register: Xofigo 1100 kBq/ml Ra-223-Dichlorid, Injektionslösung
·
- Prescription only
- Everything that fits nowhere else, such as contrast media
- Active substance
- Radii(223-Ra) dichloridum zum Kalibrierungszeitpunkt
- Made by
- Bayer (Schweiz) AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Symptomatische Knochenmetastasen bei kastrationsresistentem Prostatakarzinom
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Bayer (Schweiz) AG |
|---|---|
| Active substance | Radii(223-Ra) dichloridum zum Kalibrierungszeitpunkt |
| Used in | Everything that fits nowhere else, such as contrast media |
| Classification | V10XX03 · Everything that fits nowhere else, such as contrast media |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Xofigo 1100 kBq/ml Ra-223-Dichlorid, Injektionslösung |
| Packs | 1 Durchstechflasche(n) |
| Zulassungsnummer | 62732 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.